Omeprazol Gp (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Gp, is a Proton Pump Inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omeprazol Gp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Gp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - Erosive gastritis: reduces mucosal inflammation and promotes healing.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional mild upset. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reactions. - Liver enzyme elevation: potential hepatotoxicity. - Fracture risk: possible reduction in bone mineral density with long‑term use.

When using Omeprazol Gp, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Review long‑term therapy: monitor for bone density loss and magnesium levels. - Pregnancy and lactation: weigh benefits against potential risks. - Drug‑interaction screening: check concomitant medications for known interactions. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazol Gp may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased antiviral absorption. - Dasatinib: lowered cancer‑drug exposure.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Phenytoin: reduced phenytoin levels. - Methotrexate: possible accumulation with high‑dose regimens. - Digoxin: slight increase in serum concentrations. - Iron supplements: decreased iron absorption when taken simultaneously.